                               SEQUENCE LISTING

<110> WORCESTER POLYTECHNIC INSTITUTE
 
<120> LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE

<130> 110697-015502PCT

<140>
<141>

<150> 62/928,549
<151> 2019-10-31

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamic acid

<400> 1
Glu His Trp Ser Tyr Gly Leu Arg Pro Gly 
1               5                   10  


<210> 2
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamic acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> D-tryptophyl, D-leucyl, D-alanyl, iminobenzyl-D-histidyl,
      3-(2-naphthyl)-D-alanyl, O-tert-butyl-D-seryl, D-tyrosyl,
      D-lysyl, D-phenylalanyl, 1-benzyl-D-histidyl or 
      N-methyl-D-alanyl

<220>
<221> MOD_RES
<222> (7)..(7)
<223> L-leucyl, D-leucyl, N-alpha-methyl D-leucyl,
      N-alpha-methyl-L-leucyl or D-alanyl 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> (Aza)glycyl or absent 

<220>
<223> C-term NHR1, wherein R1 is H, lower alkyl or lower haloalkyl

<400> 2
Glu His Trp Ser Tyr Xaa Xaa Arg Pro Xaa 
1               5                   10  


<210> 3
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Pyroglutamic acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> D-amino acid

<400> 3
Glu His Trp Ser Tyr Lys Leu Arg Pro Gly 
1               5                   10  


